Free Trial
→ Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps (From Weiss Ratings) (Ad) Buy IONS Stock  Free IONS Stock Alerts

Ionis Pharmaceuticals (IONS) SEC Filings & 10K Form

Ionis Pharmaceuticals logo
$28.38 -0.30 (-1.05%)
Closing price 04:00 PM Eastern
Extended Trading
$30.11 +1.73 (+6.10%)
As of 05:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Ionis Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
03/13/2025
3:45 PM		Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:16 PM		BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:16 PM		Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:16 PM		Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:16 PM		Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:16 PM		Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:17 PM		Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:06 PM		Ionis Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/19/2025
10:15 AM		Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
3:53 PM		Capital World Investors (Filed by)
Ionis Pharmaceuticals (Subject)
Form SCHEDULE 13G
02/07/2025
10:55 AM		Ionis Pharmaceuticals (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
Form SCHEDULE 13G/A
02/06/2025
5:26 PM		Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
5:27 PM		Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:56 PM		Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
6:26 PM		BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:26 PM		Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:26 PM		HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:26 PM		Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:27 PM		Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:27 PM		Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:27 PM		Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
4:43 PM		Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
4:41 PM		Geary Richard S (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
4:01 PM		HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
4:02 PM		Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
4:03 PM		Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:58 PM		Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:59 PM		BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
6:40 PM		Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:40 PM		BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:40 PM		Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:40 PM		Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:40 PM		Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:40 PM		HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:40 PM		Ionis Pharmaceuticals (Issuer)
Jenne Kyle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:41 PM		Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:41 PM		Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:41 PM		Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:41 PM		Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:41 PM		Ionis Pharmaceuticals (Issuer)
YANG MICHAEL J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
6:31 PM		Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Warning: “DOGE Collapse” imminent (Ad)

Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.

Click here to see what they’re predicting now.
01/16/2025
6:18 PM		Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:19 PM		BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:21 PM		Birchler Brian (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:22 PM		Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:23 PM		Geary Richard S (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:25 PM		HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:28 PM		Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:29 PM		Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:30 PM		Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
10:29 AM		Ionis Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
01/06/2025
3:52 PM		Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:52 PM		BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:52 PM		Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:52 PM		Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:57 PM		Hayden Michael R (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
1:28 PM		Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
7:34 PM		BB BIOTECH AG (Filed by)
Ionis Pharmaceuticals (Subject)
Form SC 13G/A
11/13/2024
7:55 AM		Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144/A
11/08/2024
9:52 AM		Ionis Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
11/06/2024
3:06 PM		Ionis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
10:15 AM		Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
5:39 PM		Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2024
5:42 PM		Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
5:01 PM		Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2024
5:01 PM		Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
4:19 PM		Ionis Pharmaceuticals (Filer)
Form 424B5
09/09/2024
3:33 PM		Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
3:23 PM		Ionis Pharmaceuticals (Filer)
Form 424B5
09/04/2024
8:43 PM		Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:43 PM		Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:51 PM		Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:23 PM		Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144/A
09/04/2024
8:24 PM		Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
Form 144/A
09/04/2024
8:25 PM		HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144/A
09/04/2024
8:27 PM		BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144/A
09/04/2024
8:29 PM		Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144/A
09/04/2024
8:33 PM		Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4/A
09/04/2024
8:33 PM		Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144/A
09/04/2024
8:40 PM		BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:40 PM		Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:41 PM		Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:19 PM		Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
Form 144/A
09/04/2024
8:20 PM		Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
Form 144/A
09/04/2024
8:21 PM		Geary Richard S (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144/A
09/04/2024
8:02 PM		Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4/A
09/04/2024
8:06 PM		Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
Form 4/A
09/04/2024
8:11 PM		Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4/A
09/04/2024
8:13 PM		HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4/A
09/04/2024
7:51 PM		Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4/A
09/04/2024
7:52 PM		Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4/A
Warning: “DOGE Collapse” imminent (Ad)

Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.

Click here to see what they’re predicting now.
09/04/2024
7:42 PM		BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4/A
09/04/2024
7:42 PM		Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4/A
09/03/2024
6:18 PM		Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
4:27 PM		Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
2:35 PM		Ionis Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/01/2024
10:15 AM		Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2024
4:02 PM		BERTHELSEN SPENCER R (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:02 PM		Diaz Allene M. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:02 PM		HERMAN JOAN E (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:IONS) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...
Colonial Metals | Sponsored
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars
Elon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...
InvestorPlace | Sponsored
America’s Retirement Accounts Are at Risk—Here’s Why
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Trump to redistribute trillions of dollars
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
My friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...
Crypto Swap Profits | Sponsored